Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
Open Access
- 1 January 2013
- journal article
- review article
- Published by Wiley in Autoimmune Diseases
- Vol. 2013, 1-13
Abstract
Psoriasis is a chronic inflammatory disease of the skin. The causes of psoriasis are unknown, although family and twin studies have shown genetic factors to play a key role in its development. The many genes associated with psoriasis and the immune response includeTNFα, IL23, andIL12. Advances in knowledge of the pathogenesis of psoriasis have enabled the development of new drugs that target cytokines (e.g., etanercept, adalimumab, and infliximab, which target TNFα, and ustekinumab, which targets the p40 subunit of IL23 and IL12). These drugs have improved the safety and efficacy of treatment in comparison with previous therapies. However, not all patients respond equally to treatment, possibly owing to interindividual genetic variability. In this review, we describe the genes associated with psoriasis and the immune response, the biological drugs used to treat chronic severe plaque psoriasis, new drugs in phase II and III trials, and current knowledge on the implications of pharmacogenomics in predicting response to these treatments.Keywords
Funding Information
- Instituto de Salud Carlos III (FIS PI10/01740)
- Fundación Teófilo Hernando (FIS PI10/01740)
This publication has 106 references indexed in Scilit:
- TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in PsoriasisJournal of Investigative Dermatology, 2012
- Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseasesGenes & Immunity, 2011
- Association analyses identify six new psoriasis susceptibility loci in the Chinese populationNature Genetics, 2010
- Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2Nature Genetics, 2010
- Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasisNature Genetics, 2010
- Genetic evidence for involvement of the IL23 pathway in Thai psoriaticsArchives of Dermatological Research, 2009
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathwaysNature Genetics, 2009
- Polymorphisms of the IL12B and IL23R Genes Are Associated with PsoriasisJournal of Investigative Dermatology, 2008
- Psoriasis is associated with increased β-defensin genomic copy numberNature Genetics, 2007
- A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk GenesThe American Journal of Human Genetics, 2007